| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/18/2004 | EP1389101A1 Toluene sulfonamide-containing anti-tumor composition and method of use thereof |
| 02/18/2004 | EP1389100A2 Novel methods for the treatment and prevention of pain using stress-activated protein kinase inhibitors |
| 02/18/2004 | EP1389099A1 Delivery of beta-blockers through an inhalation route |
| 02/18/2004 | EP1389098A1 Delivery of antipsychotics through an inhalation route |
| 02/18/2004 | EP1389097A1 Delivery of compounds for the treatment of parkinsons through an inhalation route |
| 02/18/2004 | EP1389096A1 Delivery of opioids through an inhalation route |
| 02/18/2004 | EP1389095A1 Delivery of antidepressants through an inhalation route |
| 02/18/2004 | EP1389094A1 Delivery of sedative-hypnotics trough an inhalation route |
| 02/18/2004 | EP1389092A1 Abuse-resistant opioid dosage form |
| 02/18/2004 | EP1389091A1 Granular preparations of gaboxadol |
| 02/18/2004 | EP1389089A2 Method and composition for solubilising a biologically active compound with low water solubility |
| 02/18/2004 | EP1389044A1 Ppar-alpha-gamma ligands or agonists for the treatment of inflammation |
| 02/18/2004 | EP1325001B1 Anticholinergic agents that can be used as medicaments and method for the production thereof |
| 02/18/2004 | EP1292572B1 Propanolaminotetralines, preparation thereof and compositions containing same |
| 02/18/2004 | EP1267932B1 Anti-infective active substance combinations and the use thereof for the topical treatment of fungus diseases of toe and finger nails |
| 02/18/2004 | EP1233952B1 Pesticidal n-heteroaryl alpha-alkoximino-carboxamides |
| 02/18/2004 | EP1233786B1 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance for the preparation of a medicament |
| 02/18/2004 | EP1216248B1 Triazolopyrimidine derivatives |
| 02/18/2004 | EP1216238B1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 02/18/2004 | EP1196410B1 Respiratory syncytial virus replication inhibitors |
| 02/18/2004 | EP1194136B1 Non-solid composition for local application comprising glycerol and alchemilla vulgaris extract |
| 02/18/2004 | EP1192156B1 Bispidine compounds useful in the treatment of cardiac arrhythmias |
| 02/18/2004 | EP1187635B1 Anaesthetic formulation comprising an nmda-antagonist and an alpha-2 adrenergic agonist |
| 02/18/2004 | EP1183252B1 pharmaceutically active compounds |
| 02/18/2004 | EP1178958B1 N-cyanomethyl amides as protease inhibitors |
| 02/18/2004 | EP1178736B1 A composition containing carvacrol and thymol for use as a bactericide |
| 02/18/2004 | EP1171416B1 3-bicycloaryl-2-aminomethyl bicycloalkanes as serotonine reuptake inhibitors |
| 02/18/2004 | EP1169301B1 A topical antiandrogen for hair loss and other hyperandrogenic conditions |
| 02/18/2004 | EP1163256B1 Hemihydrate of 16.alpha.-bromoepiandrosterone |
| 02/18/2004 | EP1162980B1 Pyridoxine compounds in the treatment of cardiovascular pathologies |
| 02/18/2004 | EP1143988B1 Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of type 2 diabetes, the metabolic syndrome and associated cardiovascular diseases |
| 02/18/2004 | EP1137407B1 Ophthalmic formulation comprising a beta blocker and carbopol |
| 02/18/2004 | EP1133494B1 8-azabicyclo 3.2.1]oct-2-ene and -octane derivatives |
| 02/18/2004 | EP1133477B1 Substituted benzimidazoles and their use as parp inhibitors |
| 02/18/2004 | EP1119568B1 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
| 02/18/2004 | EP1104422B1 Phenyl xanthine derivatives |
| 02/18/2004 | EP1082293B1 Formoterol polymorphs |
| 02/18/2004 | EP1049691B1 Substituted 5-(2,2-difluoro-1,3-benzodioxol-5-yl) cyclopentenopyridine derivative |
| 02/18/2004 | EP1032396B1 Sterilization of glucocorticosteroids |
| 02/18/2004 | EP1019090B1 Polymeric derivatives of camptothecins |
| 02/18/2004 | EP1014968B1 NARINGIN AND NARINGENIN AS 3-HYDROXY-3-METHYLGLUTARYL CoA(HMG-CoA) REDUCTASE INHIBITOR |
| 02/18/2004 | EP0994696B1 Controlled release pharmaceutical preparation with ace inhibitor as active agent |
| 02/18/2004 | EP0988020B1 Use of inorganic-organic hybrid prepolymers |
| 02/18/2004 | EP0983271B1 Carbocyclic nucleoside hemisulfate and its use in treating viral infections |
| 02/18/2004 | EP0983270B1 Process for preparing 6-o-monoesters of castanospermine |
| 02/18/2004 | EP0980365B1 method for the preparation of alpha-tocopherol-4-aminobenzoic acid ester compounds |
| 02/18/2004 | EP0980351B1 Benzylamine and phenylethylamine derivatives, processes for preparing the same and their use as medicaments |
| 02/18/2004 | EP0946166B1 Use of matrix metalloproteinase inhibitors for promoting wound healing |
| 02/18/2004 | EP0944631B1 Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases |
| 02/18/2004 | EP0944627B1 8-azabicyclo 3.2.1]octane-, 8-azabicyclo 3.2.1]oct-6-ene-, 9-azabicyclo 3.3.1]nonane-, 9-aza-3-oxabicyclo 3.3.1]nonane- and 9-aza-3-thiabicyclo 3.3.1]nonane derivatives, their preparation and their use as insecticides |
| 02/18/2004 | EP0912563B1 Cinchonan based chiral selectors for separation of stereoisomers |
| 02/18/2004 | EP0876388B1 Tricyclic erythromycin derivatives |
| 02/18/2004 | EP0874855B1 Production of a salt of clavulanic acid |
| 02/18/2004 | EP0865294B1 Methods of reducing or maintaining reduced levels of blood lipids using ob protein compositions |
| 02/18/2004 | EP0863765B1 Pharmaceutical compositions of cyclosporine with a polyethoxylated saturated hydroxy-fatty acid |
| 02/18/2004 | EP0862462B1 Combination of a beta-receptor blocker and an opioid |
| 02/18/2004 | EP0851857B1 Inhibitors of tumor necrosis factor alpha |
| 02/18/2004 | EP0839134B1 Benzoyl piperidines/pyrrolidines for enhancing synaptic response |
| 02/18/2004 | EP0759922B1 New antagonist compounds |
| 02/18/2004 | EP0734264B1 Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 02/18/2004 | EP0691852B1 Valproic acid covalently bonded to a lysophospholipid |
| 02/18/2004 | CN1476479A Human protooncogene and protein encoded therein |
| 02/18/2004 | CN1476448A Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 02/18/2004 | CN1476447A Aminothiazoles and their use as adenosine receptor antagonists |
| 02/18/2004 | CN1476446A Benzodiazepine derivative |
| 02/18/2004 | CN1476445A 4-(bipheny/carbony/amino) piperidine derivatives as MTP inhibitors |
| 02/18/2004 | CN1476444A Farnesyl protein transferase inhibitors |
| 02/18/2004 | CN1476443A New desloratadine salts, process for their synthesis and pharmaceutical compositions thereof |
| 02/18/2004 | CN1476442A Pyridine derivatives with IKB-kinase (IKK-beta) INhibiting activity |
| 02/18/2004 | CN1476439A Salts of aiso thiazole-4-carboxamide and their use as anti-hyperproliferatin agents |
| 02/18/2004 | CN1476438A Fused heteroaromatic glucokinase activators |
| 02/18/2004 | CN1476436A Novel compounds for use as HIV protease inhibitors |
| 02/18/2004 | CN1476435A Fluorinated quinolones as antimitotic and antitumor agents |
| 02/18/2004 | CN1476434A Novel compounds |
| 02/18/2004 | CN1476432A Indole and dihydroindole derivatives |
| 02/18/2004 | CN1476431A Process for preparing distamycin derivatives |
| 02/18/2004 | CN1476430A Delta 1-pyrrolines used as pesticides |
| 02/18/2004 | CN1476429A EP4 receptor selective agonists in treatment of osteoporosis |
| 02/18/2004 | CN1476427A Phenoxyphenyl alkane sulfonates |
| 02/18/2004 | CN1476424A 萘衍生物 Naphthalene Derivatives |
| 02/18/2004 | CN1476335A Freeze-dried pantoprazole preparation and pantoprazole injection |
| 02/18/2004 | CN1476331A Method and preparations having effect agaist allergic symptoms |
| 02/18/2004 | CN1476329A Bactericidal disinfectant, antibacterial drug and antibacterial material |
| 02/18/2004 | CN1476328A Treatment of osteoporosis |
| 02/18/2004 | CN1476327A Water-soluble liquid internal medicine |
| 02/18/2004 | CN1476326A Treatment of PCP addiction and PCP addiction-related behavior |
| 02/18/2004 | CN1476318A O/W emulsion composition and method of preparing same |
| 02/18/2004 | CN1475571A Expression of recombination SARS virus gene in pleiomorphic Hansen yeast and its use |
| 02/18/2004 | CN1475492A Hongjingtian glycoside derivative and its preparation method and use |
| 02/18/2004 | CN1475491A Aminoglucose diphosphate and its synthesis method and preparation of medicine for treating stomash disease using said salt |
| 02/18/2004 | CN1475490A Valerian extract and its preparation method and use |
| 02/18/2004 | CN1475488A Fluoro isoflavone containing derivative, monufacturing method and its use |
| 02/18/2004 | CN1475487A Fluoro flavon containing compound, manufacturing method and its use |
| 02/18/2004 | CN1475486A Chiral 3-aryl benzo phthalein kind compound, synthesis method and use |
| 02/18/2004 | CN1475477A Method and intermdeiate used for manufacturing antifolic acid agent |
| 02/18/2004 | CN1475265A Medicament box used for treating acute anhelation syndrome |
| 02/18/2004 | CN1475225A Use of Bacille Calmette-Guerin polysaccharide nucleic acid in the preparation of medicine for oral cavity local administration |
| 02/18/2004 | CN1475224A Compound preparation of levocarnitin and adenosine triphosphate |
| 02/18/2004 | CN1475223A Compound preparation containing ribavirin and new decanoy acetaldehyde sodium and its preparation method |
| 02/18/2004 | CN1475222A Vine leaf extract and its preparation process |